Carcinoma, Basal Cell  >>  oxaliplatin  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
oxaliplatin / Generic mfg.
NCT00448552: Oxaliplatin and Capecitabine in Treating Patients With Relapsed or Metastatic Head and Neck Cancer

Completed
2
30
US
capecitabine, oxaliplatin
University of Miami
Head and Neck Cancer
04/07
06/08
NCT00959647: A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study

Completed
2
19
US
Vismodegib, Erivedge, GDC-0449, RO5450815, FOLFOX, FOLFIRI, Bevacizumab, Avastin
Genentech, Inc.
Ovarian Cancer, Basal Cell Carcinoma, Metastatic Colorectal Cancer
01/14
01/14

Download Options